Cart
sales@molnova.com
Selisistat R-enantiomer
CAS No. 848193-69-1
Selisistat R-enantiomer ( EX-527 (R-enantiomer) )
Catalog No. M26682 CAS No. 848193-69-1
Selisistat R-enantiomer is a SIRT1 inhibitor with much less activity than the R-enantiomer of Selisistat (IC50 of SIRT1 > 100 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 177 | Get Quote |
|
| 5MG | 314 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSelisistat R-enantiomer
-
NoteResearch use only, not for human use.
-
Brief DescriptionSelisistat R-enantiomer is a SIRT1 inhibitor with much less activity than the R-enantiomer of Selisistat (IC50 of SIRT1 > 100 μM).
-
DescriptionSelisistat R-enantiomer is a SIRT1 inhibitor with much less activity than the R-enantiomer of Selisistat (IC50 of SIRT1 > 100 μM).
-
SynonymsEX-527 (R-enantiomer)
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorERK; hERG; IFN-γ; JNK; NF-κB; p38 MAPK; STAT; TLR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number848193-69-1
-
Formula Weight248.7
-
Molecular FormulaC13H13ClN2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC(=O)[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu XQ, et al. [Thymopolypeptides combined with matrine type alkaloids suppress HBV replication]. Zhongguo Zhong Yao Za Zhi. 2016 Apr;41(7):1275-1281. Chinese.
molnova catalog
related products
-
E1231
E1231 (E-1231) is a small molecule SIRT1 activator with EC50 of 0.83 uM.
-
SirT1 enhancer A03
SirT1 enhancer A03 is a specific, orally bioavailable, brain penetrant apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer.
-
JGB1741
JGB1741 is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer.
